when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Rare Disease · news · pharmadog

← back to Rare Disease

News · Rare Disease

851 stories

Aug 7, 26Lexunder Inc Recalls Food to Live Brand Green Powder Products Because of Possible Health Riskfda recalls

Aug 7, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Aug 7, 26BioMarin discontinues rare disease drug; CSL and Arcturus split upendpoints

Aug 7, 26STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and morestat

Aug 7, 26Intellia finds genetic suspect for liver safety signals with ATTR gene therapybiospace

Aug 7, 26A third clinic settles with DOJ over trans carestat

Aug 7, 26Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapyfiercebiotech

Aug 7, 26BioMarin axes $270M rare disease asset after missing phase 3 endpointfiercebiotech

Aug 6, 26Third time’s the charm for Replimune as melanoma drug earns FDA greenlightbiospace

Aug 6, 26STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group assertsstat

Aug 6, 26STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and morestat

Aug 6, 26Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasstat

Aug 6, 26Covid can reactivate dormant viruses, according to studystat

Aug 6, 26CROs vs. biotechs: Finding the right fitbiospace

Aug 6, 26Actimed gets back rights to wasting disease drug, ending $126M deal with Faradayfiercebiotech

Aug 6, 26Medline Industries, LP Issues Nationwide Recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuitsfda medwatch

Aug 6, 26FDA approves Moderna’s mRNA flu vaccine, the first to use the technologystat

Aug 6, 26Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMSraps

Aug 5, 26STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatmentsstat

Aug 5, 26STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AIstat

Aug 5, 26FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptomsfda press

Aug 5, 26Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancystat

Aug 5, 26STAT+: Could poop pills be the next treatment for food allergies?stat

Aug 5, 26STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safetystat

Aug 5, 26Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employeesbiospace

Aug 5, 26Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasadbiospace

Aug 5, 26STAT+: Moderna launches early trial of Ebola mRNA vaccinestat

Aug 5, 26STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and morestat

Aug 5, 26Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcommsbiospace

Aug 5, 26MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get themstat

← prevpage 15 of 29next →